Lim M, Weller M, Idbaih A, Steinbach J, et al. Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter. Neuro Oncol 2022 May 2. pii: 6577049. doi: 10.1093.
PMID: 35511454